Perfil
Klaus Schwamborn served as Chief Development Officer at Pepscan Holding NV and Pepscan Therapeutics BV.
He also worked as Vice President-Discovery Research & Innovation at Valneva SE from 2013 to 2022.
Schwamborn holds a doctorate degree from the University of Gottingen.
Antiguos cargos conocidos de Klaus Schwamborn.
Empresas | Cargo | Fin |
---|---|---|
VALNEVA | Corporate Officer/Principal | 01/07/2022 |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Corporate Officer/Principal | - |
Pepscan Holding NV
Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Corporate Officer/Principal | - |
Formación de Klaus Schwamborn.
University of Gottingen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
VALNEVA | Health Technology |
Empresas privadas | 2 |
---|---|
Pepscan Holding NV
Pepscan Holding NV Pharmaceuticals: MajorHealth Technology Pepscan Holding NV operates as a holding company with interest in developing immunotherapeutic products in oncology. It offers proprietary technologies for the design, manufacture and use of large combinatorial arrays of peptides, peptide constructs, peptidometics and peptide derivatives. The firm operates through its subsidiaries Pepscan Systems BV and Pepscan Therapeutics BV. The company was founded in 2007 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Klaus Schwamborn